Literature DB >> 640301

NSILA-carrier protein abolishes the action of nonsuppressible insulin-like activity (NSILA-S) on perfused rat heart.

C Meuli, J Zapf, E R Froesch.   

Abstract

Human serum in a concentration of 10% in the perfusion medium failed to increase glucose uptake by the isolated perfused rat heart, indicating that nonsuppressible insulin-like activity (NSILA) in whole serum was inactive in this system. When NSILA-carrier protein was added to partially purified NSILA-S, its biological activity on the rat heart disappeared. In contrast, the action of insulin was not affected by the presence of NSILA-carrier protein. Binding of 125I-labelled NSILA-S to rat heart was inhibited by NSILA-carrier protein. 125I-labelled insulin binding was not inhibited. These results support the hypothesis that NSILA-S bound to serum carrier protein is a large molecular compound which does not readily diffuse out of the capillary bed and therefore does not exert insulin-like effects in vivo.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 640301     DOI: 10.1007/BF01219425

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  20 in total

Review 1.  Biological properties of NSILA-S.

Authors:  E R Froesch; J Zapf; C Meuli; M Mäder; M Waldvogel; U Kaufmann; B Morell
Journal:  Adv Metab Disord       Date:  1975

2.  ANTIBODY-SUPPRESSIBLE AND NONSUPPRESSIBLE INSULIN-LIKE ACTIVITIES IN HUMAN SERUM AND THEIR PHYSIOLOGIC SIGNIFICANCE. AN INSULIN ASSAY WITH ADIPOSE TISSUE OF INCREASED PRECISION AND SPECIFICITY.

Authors:  E R FROESCH; H BUERGI; E B RAMSEIER; P BALLY; A LABHART
Journal:  J Clin Invest       Date:  1963-11       Impact factor: 14.808

3.  Circulating NSILA-s in man: Preliminary studies of stimuli in vivo and of binding to plasma components.

Authors:  K Megyesi; C R Kahn; J Roth; P Gorden
Journal:  J Clin Endocrinol Metab       Date:  1975-09       Impact factor: 5.958

4.  Insulin and nonsuppressible insulin-like activity (NSILA-S) stimulate the same glucose transport system via two separate receptors in rat heart.

Authors:  C Meuli; E R Froesch
Journal:  Biochem Biophys Res Commun       Date:  1977-04-11       Impact factor: 3.575

5.  Binding of insulin and nonsuppressible insulin-like activity to isolated perfused rat heart muscle. Evidence for two separate binding sites.

Authors:  C Meuli; E R Froesch
Journal:  Arch Biochem Biophys       Date:  1976-11       Impact factor: 4.013

6.  Non-suppressible insulin-like activity of human serum. I. Physicochemical properties, extraction and partial purification.

Authors:  H Bürgi; W A Müller; R E Humbel; A Labhart; E R Froesch
Journal:  Biochim Biophys Acta       Date:  1966-06-29

7.  Non-suppressible insulin-like activity of human serum. II. Biological properties of plasma extracts with non-suppressible insulin-like activity.

Authors:  E R Froesch; W A Müller; H Bürgi; M Waldvogel; A Labhart
Journal:  Biochim Biophys Acta       Date:  1966-06-29

8.  Comparison of somatomedin activity in rat serum and lymph.

Authors:  K L Cohen; S P Nissley
Journal:  Endocrinology       Date:  1975-09       Impact factor: 4.736

9.  Demonstration of a specific serum carrier protein of nonsuppressible insulin-like activity in vivo.

Authors:  U Kaufmann; J Zapf; B Torretti; E R Froesch
Journal:  J Clin Endocrinol Metab       Date:  1977-01       Impact factor: 5.958

10.  Determination of nonsuppressible insulin-like activity in human serum by a sensitive protein-binding assay.

Authors:  J Zapf; U Kaufmann; E J Eigenmann; E R Froesch
Journal:  Clin Chem       Date:  1977       Impact factor: 8.327

View more
  13 in total

1.  Impaired glucose homeostasis in insulin-like growth factor binding protein-1 transgenic mice.

Authors:  K Rajkumar; M Krsek; S T Dheen; L J Murphy
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

2.  Insulin-like growth factor binding proteins from cultured human fibroblasts. Characterization and hormonal regulation.

Authors:  C A Conover; F Liu; D Powell; R G Rosenfeld; R L Hintz
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

3.  Acute metabolic effects and half-lives of intravenously administered insulinlike growth factors I and II in normal and hypophysectomized rats.

Authors:  J Zapf; C Hauri; M Waldvogel; E R Froesch
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

4.  Inhibition of the action of nonsuppressible insulin-like activity on isolated rat fat cells by binding to its carrier protein.

Authors:  J Zapf; E Schoenle; G Jagars; I Sand; J Grunwald; E R Froesch
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

Review 5.  Hormonal derangements in uremia.

Authors:  G Tolis; D Goltzman; H Guyda; T Mountokalakis
Journal:  J Endocrinol Invest       Date:  1980 Jan-Mar       Impact factor: 4.256

6.  Recombinant human insulin-like growth factor I induces its own specific carrier protein in hypophysectomized and diabetic rats.

Authors:  J Zapf; C Hauri; M Waldvogel; E Futo; H Häsler; K Binz; H P Guler; C Schmid; E R Froesch
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

7.  Human plasma fractions inhibit the action of insulin on adipocytes and somatomedin on cartilage.

Authors:  N Avasthy; M A Khokher; A M Taylor; P Dandona
Journal:  Diabetologia       Date:  1986-07       Impact factor: 10.122

8.  Expression and regulation of insulin-like growth factor binding protein-1 in the rat uterus throughout estrous cycle.

Authors:  A Ghahary; J Luo; L J Murphy
Journal:  Mol Cell Biochem       Date:  1993-07-07       Impact factor: 3.396

9.  Preferential association of the insulin-like growth factors I and II with metabolically inactive and active carrier-bound complexes in serum.

Authors:  H J Cornell; G Enberg; A C Herington
Journal:  Biochem J       Date:  1987-02-01       Impact factor: 3.857

10.  The effects of infusion of insulinlike growth factor (IGF) I, IGF-II, and insulin on glucose and protein metabolism in fasted lambs.

Authors:  R G Douglas; P D Gluckman; K Ball; B Breier; J H Shaw
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.